Genomic profiling and prognostic factors of H3 K27M‐mutant spinal cord diffuse glioma
Open Access
- 7 February 2023
- journal article
- research article
- Published by Wiley in Brain Pathology
- Vol. 33 (4) , e13153
Abstract
H3 K27‐altered diffuse midline glioma is a highly lethal pediatric‐type tumor without efficacious treatments. Recent findings have highlighted the heterogeneity among diffuse midline gliomas with different locations and ages. Compared to tumors located in the brain stem and thalamus, the molecular and clinicopathological features of H3 K27‐altered spinal cord glioma are still largely elusive, thus hindering the accurate management of patients. Here we aimed to characterize the clinicopathological and molecular features of H3 K27M‐mutant spinal cord glioma in 77 consecutive cases. We found that the H3 K27M‐mutant spinal cord glioma, with a median age of 35 years old, had a significantly better prognosis than H3 K27M‐mutant brain tumors. We noticed a molecular heterogeneity of H3 K27M‐mutant spinal cord astrocytoma via targeted sequencing with 34 cases. TP53 mutation which occurred in 58.8% of cases is mutually exclusive with PPM1D (26%) and NF1 (44%) mutations. The TP53‐mutant cases had a significantly higher number of copy number variants (CNV) and a marginally higher proportion of pediatric patients (age at diagnosis 10%) are associated with a worse prognosis. Interestingly, the histological type, an independent prognostic factor in multivariate Cox regression, can also stratify molecular features of H3 K27M‐mutant spinal cord glioma, including the RB pathway, KRAS/PI3K pathway, and chromosome arms CNV. In conclusion, although all H3 K27M‐mutant spinal cord diffuse glioma were diagnosed as WHO Grade 4, the histological type, molecular features representing chromatin instability, and molecular alterations associated with accelerated cell proliferative activity should not be ignored in clinical management.Keywords
Funding Information
- Beijing Nova Program (Z201100006820118)
- National Natural Science Foundation of China (81903078, 82172783)
This publication has 42 references indexed in Scilit:
- Characteristics of H3 K27M-mutant gliomas in adultsNeuro-Oncology, 2017
- Functionally defined therapeutic targets in diffuse intrinsic pontine gliomaNature Medicine, 2015
- Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem gliomaNature Medicine, 2014
- Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytomaNature Genetics, 2014
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of GlioblastomaCancer Cell, 2012
- Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomasActa Neuropathologica, 2012
- K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomasActa Neuropathologica, 2012
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastomaNature, 2012
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasNature Genetics, 2012
- Altered Telomeres in Tumors with ATRX and DAXX MutationsScience, 2011